← Back to Search

Strength and Balance Exercise for Tumors (STABLE Trial)

N/A

Recruiting

Led By Schroder Sattar, RN, PhD

Research Sponsored by University of Saskatchewan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3 & 6 months - to measure change

Awards & highlights

STABLE Trial Summary

This trial aims to see if an exercise program can help reduce falls in elderly cancer patients, and inform the design of a larger study.

STABLE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3 & 6 months - to measure change

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3 & 6 months - to measure change

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 & 6 months - to measure change for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

30-second Chair Stand test

Balance test

Fall assessment

STABLE Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention groupExperimental Treatment1 Intervention

Participants in the IG will receive the STABLE intervention, which entails orientation, and undertaking a remotely delivered resistance and balance training regimen 3 times weekly for 3 months

Group II: Control groupActive Control1 Intervention

Participants in the CG will not receive the intervention, and will be advised to carry out their usual daily activities.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of SaskatchewanLead Sponsor

251 Previous Clinical Trials

154,336 Total Patients Enrolled

Saskatchewan Health Research FoundationOTHER

32 Previous Clinical Trials

4,915 Total Patients Enrolled

Schroder Sattar, RN, PhDPrincipal InvestigatorCollege of Nursing

Media Library

Strength and balance exercise Clinical Trial Eligibility Overview. Trial Name: NCT04518098 — N/A

Tumors Research Study Groups: Control group, Intervention group

Tumors Clinical Trial 2023: Strength and balance exercise Highlights & Side Effects. Trial Name: NCT04518098 — N/A

Strength and balance exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT04518098 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities for enrollment in this research trial?

"Affirmative. The data available on clinicaltrials.gov reveals that this trial is currently recruiting patients, which was initially posted on January 1st 2023 and last revised on May 8th 2023. This investigation requires 74 participants from a single site to participate in the study."

Answered by AI

How many individuals have been allocated into this trial?

"Affirmative. Data from clinicaltrials.gov reveals that this healthcare trial, which was first featured on January 1st 2023, is currently recruiting patients. Approximately 74 individuals must be enrolled at a single site to complete the study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

STABLE (Strength Training and Balance Leg Exercise) Study

Schroder Sattar 2023. "STABLE (Strength Training and Balance Leg Exercise) Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04518098.